The technical requirements for a Drug Master File (DMF) in China include detailed information on the drug components’ manufacturing process, quality control, stability data, and compliance with Chinese Pharmacopoeia standards. Additionally, documentation must be submitted in Chinese, and the DMF must align with the National Medical Products Administration (NMPA) guidelines.